久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Sage soars on postpartum depression data pharmaphorum
    January 10, 2019
    Sage Therapeutics has scored a big win with postpartum depression (PPD) drug SAGE-217, after rolling the dice on an upgraded clinical trial last summer.
  • Sage Therapeutics’ Postpartum Depression Drug Heads to the FDA biospace
    April 24, 2018
    SAGE Therapeutics,?located in Cambridge, Massachusetts, has?submitted?a New Drug Application (NDA) to the?U.S.?Food and Drug Administration (FDA)?for brexanolone (SAGE-547) to treat postpartum depression (PPD).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service